Insider Selling: Inspire Medical Systems, Inc. (NYSE:INSP) Insider Sells 25,584 Shares of Stock

Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) insider Randy Ban sold 25,584 shares of Inspire Medical Systems stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $183.50, for a total value of $4,694,664.00. Following the completion of the transaction, the insider now owns 7,259 shares in the company, valued at $1,332,026.50. This trade represents a 77.90 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Inspire Medical Systems Stock Down 0.9 %

Shares of INSP traded down $1.52 on Friday, reaching $176.87. The stock had a trading volume of 436,322 shares, compared to its average volume of 609,751. The firm has a 50-day moving average of $188.14 and a 200 day moving average of $192.70. The firm has a market capitalization of $5.25 billion, a PE ratio of 102.24, a PEG ratio of 2.87 and a beta of 1.32. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its earnings results on Monday, February 10th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. On average, sell-side analysts anticipate that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on INSP. Royal Bank of Canada restated an "outperform" rating and issued a $260.00 target price on shares of Inspire Medical Systems in a research note on Tuesday, February 11th. Truist Financial lowered their price objective on Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating on the stock in a report on Tuesday, February 11th. Wells Fargo & Company dropped their target price on Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating on the stock in a research report on Tuesday, February 11th. KeyCorp reissued an "overweight" rating and issued a $234.00 price target (down from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Finally, Piper Sandler decreased their price target on Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $228.82.

Institutional Investors Weigh In On Inspire Medical Systems

Large investors have recently added to or reduced their stakes in the business. First Horizon Advisors Inc. lifted its holdings in shares of Inspire Medical Systems by 885.7% in the fourth quarter. First Horizon Advisors Inc. now owns 138 shares of the company's stock valued at $26,000 after purchasing an additional 124 shares in the last quarter. True Wealth Design LLC acquired a new position in shares of Inspire Medical Systems during the 3rd quarter worth approximately $30,000. Farther Finance Advisors LLC lifted its stake in Inspire Medical Systems by 1,158.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 151 shares of the company's stock valued at $32,000 after buying an additional 139 shares in the last quarter. Huntington National Bank grew its holdings in Inspire Medical Systems by 228.3% during the 4th quarter. Huntington National Bank now owns 174 shares of the company's stock valued at $32,000 after buying an additional 121 shares during the last quarter. Finally, Harbour Investments Inc. increased its position in Inspire Medical Systems by 101.0% during the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company's stock worth $37,000 after buying an additional 99 shares in the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.